Copyright
©The Author(s) 2021.
World J Gastrointest Surg. Sep 27, 2021; 13(9): 1063-1078
Published online Sep 27, 2021. doi: 10.4240/wjgs.v13.i9.1063
Published online Sep 27, 2021. doi: 10.4240/wjgs.v13.i9.1063
Ref. | Methodology | n | Age | Follow-up | Diagnosis and assessment | Outcome | Complications |
Balata et al[23], 2020 (Egypt) | RCT | 32 (entire cohort n = 64) | 45.1 ± 3.5 | 12 mo | Wexner constipation score; Fluoroscopic defecography; ARM; PISQ-12; Satisfaction | Significant improvement (decline) in Wexner score (Pre = 18.3 ± 0.7, PO = 7.2 ± 1.4, P < 0.0001) | Complications (n = 6); Dyspareunia (Pre = 11, PO =13, P = 0.8); Recurrence (n = 2) |
Significant decline in rectocele depth (Pre = 4.6 ± 0.8 cm, PO = 1.4 ± 0.9 cm, P < 0.0001) | |||||||
Significant rise of MRP (Pre = 60.7 ± 8.5 mmHg, PO = 67.1 ± 4.2 mmHg, P = 0.0003) | |||||||
Significant rise of MSP (Pre = 136.4 ± 3.5 mmHg, PO = 141.2 ± 2.1 mmHg, P < 0.0001) | |||||||
Significant improvement (decline) in PISQ-12 score (Pre = 26.4 ± 2.1, PO = 18.2 ± 0.7, P < 0.0001) | |||||||
Sexual satisfaction (Pre = 23 patient, PO = 24 patient, P = 0.8) | |||||||
Emile et al[24], 2020 (Egypt) | Retrospective case series | 46 | 43.2 ± 10.7 | 13.9 mo (12.0-18.0) | Wexner constipation score; Fluoroscopic defecography; ARM | Significant improvement (n = 30), no improvement (n = 16) | Wound dehiscence (n = 6), hematoma (n = 2) |
Significant improvement (decline) in Wexner score (Pre = 17.8 ± 2.7, PO = 9.2 ± 4.7, P < 0.001) | |||||||
Significant decline in rectocele depth (Pre = 4.7 ± 1.2, PO = 2.2 ± 1.4, P < 0.001) | |||||||
Significant improvement (decline) in rectal sensation volumes | |||||||
Tomita et al[25], 2012 (Japan) | Prospective case series | 12 | 63.3 (33.0-82.0) | 24 mo | Symptom assessment; Fluoroscopic defecography | Symptom improvement [excellent (n = 6 patient), good (n = 4 patient), fair (n = 2 patient)] | Wound infection (n = 2) |
Significant decline in rectocele depth (Pre = 4 ± 0.8 cm, PO = 0.2 ± 0.5 cm, P <0.001) | |||||||
Complete resolution of rectocele (n = 10 patient) | |||||||
Mills[26], 2011 (South Africa) | Retrospective case series | 117 | 24-85 | 6 mo (at least) | Symptom assessment; Trans-labial US; Rectocele wall thickness by Harpenden Skinfold Caliper (n = 50 patient); Trans-illumination (n = 50 patient) | Negative trans-illumination immediately after repair (n = 50 patient) | Wound infection (n = 2) |
Rectocele wall thickness increased from 2.4 mm to 4.8 mm immediately after repair (n = 50 patient) | |||||||
No PO manifestations of FI (n = 109 patient) | |||||||
Patients with combined ODS and FI became normal (n = 43 patient) | |||||||
Farid et al[27], 2010 (Egypt) | RCT | 16 (entire cohort n = 47) | 48.4 ± 12.6 | 6 mo | Modified ODS score; Fluoroscopic defecography; ARM | Significant improvement (decline) in modified ODS score (Pre = 17.3 ± 5.1, PO = 3.8 ± 1.7, P < 0.0001) | Wound infection (6.4%) |
Significant reduction in rectocele depth (Pre = 4.2 ± 0.8 cm, PO = 0.9 ± 0.7 cm, P < 0.0001) | |||||||
Significant improvement in rectal sensation volumes; Non-significant decline of dyspareunia (Pre = 6 patients, PO = 3 patients) | |||||||
Complete rectal evacuation (n = 13 patient) | |||||||
Significant correlation between rectocele depth and ODS score (P = 0.01) | |||||||
Puigdollers et al[28], 2007 (Spain) | Prospective cohort | 24 (entire cohort n = 35) | 52 (28-79) | 12 mo | Questionnaire based on ROME-II criteria (Y/N) | Significant decline in PO score (Pre = 4.2, PO = 1.9, P < 0.0001) | Hematoma (n = 2) |
Improvement: complete improvement [no symptoms] (42.9%), partial improvement [only one symptom] (5.7%), partial improvement [with ≥ 2 symptom] (31.4%), unchanged (20%) | |||||||
Improvement of constipation (n = 11 patient) | |||||||
Results were worse after hysterectomy | |||||||
Hirst et al[29], 2005 (United Kingdom) | Retrospective cohort | 33 (entire cohort n = 82) | 51, median (25-83) | NP | Clinical assessment; Satisfaction assessment | Surgery outcome: All patients: Cured (n = 21 patient), initial improvement (n = 5 patient), no improvement (n = 7 patient), further surgery (n = 8 patient) | Complications (n = 0); Recurrence (n = 5) |
Patients with rectocele only (n = 6 patients): Cured (n = 5), initial improvement (n = 1), further surgery (n = 0) Satisfaction: (n = 26) | |||||||
Ayabaca et al[30], 2002 (Italy) | Retrospective cohort | 11 (entire cohort n = 60) | 56 (21-70) | 48 mo (9-122) | Symptom assessment; FI score; ARM | ODS symptoms improvement: Improved (n = 8 patient), lost to follow-up (n = 3 patient) | Urine retention (10%), wound dehiscence (6.6%), wound infection (n = 3.3%), other complications (10%); Recurrence: n = 0 |
FI score improved (declined: Pre = 4.9 ± 0.9, PO = 4.2 ± 0.8); Non-significant decline in MRP and MSP in patients with FI | |||||||
No improvement of FI (n = 1 patient) | |||||||
Van Laarhoven et al[31], 1999 (United Kingdom) | Retrospective cohort | 10 (entire cohort n = 22) | 48 (31-63) | 27 mo, median (5-54) | Symptom assessment; Fluoroscopic defecography; Pudendal nerve motor latency | Ability to evacuate rectum: Improved (72.7%), unchanged (22.7%), deteriorated (4.5%) | Wound infection (9.1%) |
Significant decline in rectocele depth (Pre = 2.9 cm, PO = 1.7 cm, P < 0.01) | |||||||
Significant decline in rectocele area (Pre = 7.8 cm, PO = 4.3 cm, P < 0.01) | |||||||
No correlation between rectocele reduction and symptoms improvement |
Ref. | Methodology | Technique | n | Age | Follow-up | Diagnosis and Assessment | Outcome | Complications |
Ellis[32], 2010 (United States) | Retrospective cohort | TPI [porcine intestinal submucosal collagen implant (Surgisis®)] ± SP | 32 (entire cohort n = 120) | 58.7 ± 8.9 | 12 mo | BBUSQ-22 | Improvement of BBUSQ-22 individual items (total improvement 30.9%): Significant improvement (decline) in 6 items | Urine retention (n = 2), Recurrence (n = 0) |
Significant deterioration (raise) in pain with bowel movements | ||||||||
Non-significant changes in 2 items | ||||||||
Smart and Mercer-Jones[33], 2007 (United Kingdom) | Prospective case series | TPI [porcine dermal collagen implant (Permacol®)]> Suction drain (last 8 patients) | 10 | 51, median (33-71) | 9 mo, median (5-16) | Watson score | All patients (100%) had improvement in 2 or more symptoms, and 70% in three or more | Hematoma (n = 2) |
Decline of Watson score (Pre = 10.5, PO = 4.5) | ||||||||
Hirst et al[29], 2005 (United Kingdom) | Retrospective cohort | TPR + LP + Implant | 7 (entire cohort n = 82) | 51, median (25-83) | NP | Clinical assessment | Surgery outcome: cured (n = 5 patient), initial improvement (n = 1 patient), no improvement (n = 1 patient), further surgery (n = 2 patient); Satisfaction: n = 6 patient | Mesh erosion (n = 1); Recurrence (n = 1) |
Mercer-Jones et al[34], 2004 (United Kingdom) | Retrospective case series | TPI ± SPProlene mesh (n = 14),Prolene + PGA mesh [Vypro II®] (n = 8) | 22 | 53, median (28-66) | 12.5 mo (3.0-47.0) | Watson score | Decline in Watson score (Pre = 11.1, PO = 3.9); Significant (P < 0.05) symptomatic improvement (n = 20 patient) | Wound infection (n = 2), wound infection and dehiscence (n = 1), dyspareunia (n = 1) Recurrence (n = 1) |
Subjective outcome (P < 0.05) in favor of Vypro II® mesh: Moderate to excellent [Prolene (n = 9 patient), Vypro II® (n = 8 patient)] | ||||||||
Poor [prolene (n = 5 patient), Vypro II® (n = 0 patient)] | ||||||||
Azanjac and Jorovic[35], 1999 (Serbia) | Prospective case series | TPI [prolene mesh (Atrium®)] | 6 | 56 (46-68) | 11 mo (7-18) | Symptom assessment; Satisfaction assessment | Successful rectal evacuation without digitation (n = 6 patient); Symptom improvement [markedly (n = 2 patient), completely (n = 4 patient)] | Urine retention (n = 1) |
Satisfaction [very satisfied (n = 5 patient), somewhat (n = 1 patient)] | ||||||||
Watson et al[36], 1996 (United Kingdom) | Prospective case series | TPR + LP + Implant [prolene mesh (Marlex®)] | 9 | 50, median (32-61) | 29 mo, median (8-36) | Watson scoreFluoroscopic defecography | Significant decline in PO score (Pre = 11.7, PO = 1.9, P < 0.05); No further need for digital evacuation (n = 8); Significant decline in rectocele depth (Pre = 3.7, PO = 2.4, P < 0.05) | Wound infection (n = 1); Dyspareunia: Resolved (n = 1), abstained (n = 2), acquired (n = 1) |
Significant decline in barium trapping (Pre = 14%, PO = 5%, P < 0.005) |
Ref. | Method-ology | Technique (TPR) | n | Age | Follow-up | Diagnosis and assessment | Outcome | Complications |
Omar et al[37], 2020 (Egypt) | Pilot RCT | Omission of levatorplasty only (n = 20) HP instead of classical plication (n = 20) | 40 | 44.9 (± 7.7) | 12 mo | Wexner constipation score; Fluoroscopic defecography; ARM | Cure rate: Complete cure: TPR (n = 13 patient), HP (n = 11 patient) | TPR [wound dehiscence (n = 3), bleeding (n = 1), recurrence (n = 3)], HP [wound dehiscence (n = 1), bleeding (n = 1) recurrence (n = 1)] |
Significant improvement TPR (n = 6 patient), HP (n = 8 patient) | ||||||||
No improvement TPR (n = 1 patient), HP (n = 1 patient) | ||||||||
Comparable significant improvement (decline) in Wexner score in both | ||||||||
More decline in rectocele depth with HP [TPR = 2.6 ± 0.5 cm, HP = 1.7 ± 0.5 cm, P < 0.0001] | ||||||||
More improvement of dyspareunia with HP [TPR = 9 patient, HP = 2 patient, P = 0.03] | ||||||||
Sari et al[38], 2019 (Turkey) | Retrospective cohort | Omission of levatorplasty only (n = 6)+ Implant [prolene mesh without fixation (n = 6)] | 12 (entire cohort n = 78) | 52 (31-88) | 54 mo (3-218) | Symptom assessment Fluoroscopic defecography | Patients free of symptoms (78.2%) | Wound infection (3.8%), bleeding (2.6%); Recurrence (n = 0) |
Patients had remaining urinary or defecatory symptoms or PO pain (21.8%) | ||||||||
Lisi et al[39], 2018 (Italy) | Prospective case series | SSR + Implant [porcine dermal collagen implant (Permacol®)] | 25 | 47 (30-62) | 12-24 mo | Watson score; Fluoroscopic defecography; ARMSF-36 | No complaint regarding bowel functions at 2 mo and no sexual problemsSignificant decline in Watson score (Pre = 9.9 ± 2.5, PO = 2.1 ± 0.3, P < 0.0001) | UTI (n = 2), delayed wound healing (n = 4), Recurrence (n = 3) |
All PO rectocele depths were < 2 cm | ||||||||
Non-significant rise in MRP and MSP | ||||||||
Non-significant improvement of both composites of SF-36 | ||||||||
Youssef et al[40], 2017 (Egypt) | RCT | Omission of levatorplasty only (n = 30)+ LIS (n = 30) | 60 | 41.4 (17.0-70.0) | 17.8 mo (6.0-36.0) | Wexner score; Fluoroscopic defecography; ARMPAC-QOL | Complete clinical improvement 70% (TPR) vs 93.3% (TPR + LIS) | TPR [ecchymosis (n = 1), wound dehiscence (n = 2), dyspareunia (n = 1), recurrence (n = 3)] |
More decline in Wexner score with addition of LIS (TPR = 11.1 ± 2.1, TPR + LIS = 8 ± 2, P < 0.0001) | TPR + LIS [wound infection (n = 1), wound dehiscence (n = 3), FI (n = 2), dyspareunia (n = 1), recurrence (n = 1)] | |||||||
More satisfaction with TPR + LIS | ||||||||
Score: (TPR = 11.4 ± 2.7, TPR + LIS = 12.9 ± 2.3, P = 0.02); n of patients: (TPR = 21 patient, TPR + LIS = 28 patient, P = 0.04) | ||||||||
More improvement (decline) in MRP with TPR + LIS (TPR = 87.5 ± 5.1 mmHg, TPR + LIS = 74.4 ± 3.5 mmHg, P < 0.0001) | ||||||||
Farid et al[27], 2010 (Egypt) | RCT | Omission of levatorplasty only | 15 (entire cohort n = 47) | 48.4 ± 12.6 | 6 mo | Modified ODS score; Fluoroscopic defecography; ARM | Significant improvement (decline) in ODS score (Pre = 16.4 ± 6.3, PO = 7.7 ± 2.5, P < 0.001) | Wound infection (6.4%) |
Significant decline in rectocele depth (Pre = 3.8 ± 1 cm, PO = 0.9 ± 0.8 cm, P < 0.001) | ||||||||
Significant improvement in rectal sensations | ||||||||
Decline of dyspareunia (Pre = 6 patient, PO = 5 patient) | ||||||||
Complete rectal evacuation (n = 10 patient) | ||||||||
Significant correlation between rectocele depth and ODS score (P = 0.001) | ||||||||
Milito et al[41], 2010 (Italy) | Retro-spective case series | SSR + Implant [porcine dermal collagen implant (Permacol®)] | 10 | 47.7 (25.0-70.0) | 2-20 mo | Watson score; Fluoroscopic defecography; ARMSF-36 | Significant decline in Watson score (Pre = 9.6 ± 1.8, PO = 1.6 ± 0.6, P < 0.0001) | UTI (n = 1), delayed wound healing (n = 1); Recurrence (n = 2) |
Significant decline in rectocele depth (Pre = 3.8 cm, PO < 2 cm, P < 0.0001) | ||||||||
Prospective case series | SSR + Implant [PGA mesh (Soft PGA Felt®)] | 83 | 49, median (29-56) | 14 mo, median (6-36) | Watson score; Fluoroscopic defecography (n = 55); POP-Q | Significant improvement of Watson score (Pre = 9.9 ± 1.9, PO = 1.6 ± 0.6, P < 0.0001) | Bleeding (n = 3), wound infection (n = 4), dyspareunia (n = 8); Recurrence (NP) | |
Subjective cure rate (n = 83 patient); PO rectocele depth < 2cm (n = 21 patient) | ||||||||
At 6m, anatomical cure (n = 74 patient), POP-Q stage II (n = 9 patient), at 14 m, POP-Q stage II (n = 10 patient) | ||||||||
Would redo surgery if symptoms recur (n = 80 patient) |
Ref. | Methodology | Technique | n | Age | Follow-up | Diagnosis and assessment | Outcome | Complications |
Fischer et al[43], 2005 (Germany) | Retrospective cohort | TPLP | 10(entire cohort n = 36) | 59 (30-79) | 36 mo (8-110) | Symptom assessment; Fluoroscopic defecography; ARM | Symptom improvement (cured): n = 9 patientAll patients (n = 7) showed improvement in FI | RVF (n = 1), wound infection (n = 1), dyspareunia (n = 1) |
3 out of 6 patients showed no rectocele with defecography | ||||||||
Non-significant rise of both MRP and MSP | ||||||||
Satisfaction with functional outcomes: n = 9 patient | ||||||||
Boccasanta et al[44], 2001 (Italy) | Retrospective cohort | TPLP (addition of prolene mesh in 2 patients) | 126(entire cohort n = 317) | 52.4 (28.0-80.0) | 22.8 – 27.5 mo | Symptom assessment; Fluoroscopic defecography; ARM | Outcome (n = 110 patient) at 12 m: excellent (n = 45 patient), fair (n = 58 patient), poor (n = 7 patient) | Vaginal stenosis (n = 2) |
PO defecography: complete absence (44.1%), residual (55.9%); Non-significant rise of both MRP and MSP | ||||||||
Lamah et al[45], 2001 (United Kingdom) | Retrospective case series | TPLP ± SP> suction drain | 44 | 57.5 (35.0-82.0) | 42 mo (6-84) | Symptom assessment; Continence assessment; Sexual function assessment; Satisfaction assessment | Symptom assessment: TPLP (n = 33 patient): improvement of lump sensation (n = 28 patient), improvement of defecation (n = 29 patient); TPLP + SP (n = 11 patient): improvement of one or both (n = 8 patient) | Wound infection (n = 2), deteriorated FI (n = 1), dyspareunia (n = 2) |
Continence (n = 11 patient): at Pre [continent (n = 0), incontinent (n = 11)], at 12 mo [continent (n = 5), incontinent (n = 6)], at 24 mo [continent (n = 3), incontinent (n = 8)], > 36 mo [continent (n = 3), incontinent (n = 8)] | ||||||||
Sexual function: TPLP [Improved (n = 8), unchanged (n = 9), deteriorated (n = 2), declined (n = 10)]; TPLP + SP [Improved (n = 2), unchanged (n = 2), deteriorated (n = 0), declined (n = 5)] | ||||||||
Satisfaction (satisfied / total): TPLP [at 2 yr: (n = 30/33), at 3.2 yr (n = 21/24)]; TPLP + SP [at 2 yr (10/11), at 3.2 yr (6/11)] | ||||||||
Van Laarhoven et al[31], 1999 (United Kingdom) | Retrospective cohort | TPI + LP [prolene mesh (Marlex®)] | 5 (entire cohort n = 22) | 52.1 (31.0-81.0) | 27 mo, median (5-54) | Symptom assessmentFluoroscopic defecographyPudendal nerve motor latency | Ability to evacuate rectum: improved (72.7%), unchanged (22.7%), deteriorated (4.5%); Significant decline in feeling of incomplete evacuation (Pre = 86.4%, PO = 45.5%, P = 0.01); Significant decline in rectocele depth (Pre = 2.9 cm, PO = 1.7 cm, P < 0.01); Significant decline in rectocele area (Pre = 7.8 cm, PO = 4.3 cm, P < 0.01); No correlation between rectocele reduction and symptoms improvement | Wound infection (9.1%) |
Parker and Phillips[46], 1993 (United Kingdom) | Retrospective case series | TPI + LP [prolene mesh (Marlex®)] | 4 | 42-65 | 14 mo (6-18) | Symptom assessment | Successful rectal evacuation without digitation (n = 3), digitation occasionally (n = 1); Satisfaction (n = 4) | NP |
- Citation: Fathy M, Elfallal AH, Emile SH. Literature review of the outcome of and methods used to improve transperineal repair of rectocele. World J Gastrointest Surg 2021; 13(9): 1063-1078
- URL: https://www.wjgnet.com/1948-9366/full/v13/i9/1063.htm
- DOI: https://dx.doi.org/10.4240/wjgs.v13.i9.1063